Mouth cancer in inflammatory bowel diseases
- 14 January 2016
- journal article
- review article
- Published by Wiley in Oral Diseases
- Vol. 22 (4) , 260-264
Abstract
Mouth cancer is a major health problem. Multiple risk factors for developing mouth cancer have been studied and include history of tobacco and alcohol abuse, age over 40, exposure to ultraviolet radiation, human papilloma virus infection (HPV), nutritional deficiencies, chronic irritation, and existence or oral potentially malignant lesions such as leukoplakia and lichen planus. An important risk factor for mouth cancer is chronic immunosuppression and has been extensively reported after solid organ transplantation as well as HIV‐infected patients. Diagnosis of inflammatory bowel disease (IBD) is not yet considered as a risk factor for oral cancer development. However, a significant number of patients with IBD are receiving immunosuppressants and biological therapies which could represent potential oral oncogenic factors either by direct oncogenic effect or by continuous immunosuppression favoring carcinogenesis, especially in patients with HPV(+) IBD. Education on modifiable risk behaviors in patients with IBD is the cornerstone of prevention of mouth cancer. Oral screening should be performed for all patients with IBD, especially those who are about to start an immunosuppressant or a biologic.Keywords
This publication has 35 references indexed in Scilit:
- Use of Immunosuppressants and Biologicals in Patients with Previous CancerDigestive Diseases, 2013
- Plattenepithelkarzinom an der Unterlippe nach der Anwendung eines topischen CalcineurininhibitorsJDDG: Journal der Deutschen Dermatologischen Gesellschaft, 2013
- Use of Azathioprine and the Risk of Cancer in Inflammatory Bowel DiseaseAmerican Journal of Epidemiology, 2013
- Association of p16INK4a overexpression with improved outcomes in young patients with squamous cell cancers of the oral tongueHead & Neck, 2010
- Sequential treatment with biologics: switching from efalizumab to etanercept in 35 patients with high‐need psoriasisJournal of the European Academy of Dermatology and Venereology, 2010
- EBV Positive Mucocutaneous Ulcer—A Study of 26 Cases Associated With Various Sources of ImmunosuppressionAmerican Journal of Surgical Pathology, 2010
- Noncolorectal Malignancies in Inflammatory Bowel Disease: More than Meets the EyeDigestive Diseases, 2009
- Treatment of Oropharyngeal Cancer in Renal Transplant Recipients Without Cessation of Immunosuppressive TherapyTransplantation Proceedings, 2006
- Adenocarcinoma of the Mouth in a Patient with Psoriasis under Short-Term Cyclosporine TherapyDermatology, 1996
- Increased Prevalence of Dysplastic and Malignant Lip Lesions in Renal-Transplant RecipientsNew England Journal of Medicine, 1995